• Dec 09, 2024

Donald Trump: The Crypto President

His July speech at the Bitcoin Conference, in Nashville, was a turning point for crypto, promising an easier path for the industry heading into 2025.

  • Dec 09, 2024

What's Going On With Eli Lilly Stock On Tuesday?

On Monday, Eli Lilly And Co (NYSE:LLY) announced results from the Phase 3 BRUIN CLL-321 trial evaluating pirtobrutinib in adult patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) previously treated with a covalent BTK inhibitor. The study’s primary endpoint of progression-free survival (PFS) was met at primary analysis, demonstrating pirtobrutinib was superior to the investigator’s choice of idelalisib plus rituximab (IdelaR) or bendamustine plus rituximab (BR). A

  • Dec 09, 2024

CervoMed's Dementia Candidate Fails In Mid-Stage Study, Stock Plummets

On Tuesday, CervoMed Inc. (NASDAQ:CRVO) stock is trading lower after the company revealed topline data from the RewinD-LB Phase 2b clinical trial evaluating neflamapimod for dementia with Lewy bodies (DLB). The trial did not meet statistical significance thresholds for its primary endpoint of change in the Clinical Dementia Rating Sum of Boxes (a measure of dementia severity) or any of its key secondary endpoints – change from baseline in Timed Up and Go (measures a person’s mobility, balance, a